MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Read More…
Industry, Sector and Symbol
Industry Life insurance
Sub-IndustryLife & Health Insurance
SectorFinance
Phone212-578-9500
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$67.94 billion
Profitability
Miscellaneous
Employees48,000
Next Earnings Date2/5/2020 (Confirmed)
OptionableOptionable
Metlife (NYSE:MET) Frequently Asked Questions
What is Metlife's stock symbol?
Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."
How often does Metlife pay dividends? What is the dividend yield for Metlife?
Metlife declared a quarterly dividend on Tuesday, January 7th. Investors of record on Tuesday, February 4th will be paid a dividend of $0.44 per share on Friday, March 13th. This represents a $1.76 dividend on an annualized basis and a yield of 3.40%. The ex-dividend date is Monday, February 3rd. View Metlife's Dividend History.
How will Metlife's stock buyback program work?
Metlife declared that its Board of Directors has authorized a stock repurchase plan on Thursday, November 1st 2018, which authorizes the company to buyback $2,000,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 4.6% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's board believes its stock is undervalued.
How were Metlife's earnings last quarter?
Metlife Inc (NYSE:MET) posted its quarterly earnings data on Wednesday, October, 30th. The financial services provider reported $1.27 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.40 by $0.13. The financial services provider had revenue of $16.92 billion for the quarter, compared to the consensus estimate of $16.37 billion. Metlife had a return on equity of 8.82% and a net margin of 10.82%. The business's revenue for the quarter was up 3.2% compared to the same quarter last year. During the same period in the previous year, the company earned $1.38 earnings per share. View Metlife's Earnings History.
When is Metlife's next earnings date?
How can I listen to Metlife's earnings call?
Metlife will be holding an earnings conference call on Wednesday, February 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What price target have analysts set for MET?
9 brokerages have issued twelve-month price targets for Metlife's stock. Their forecasts range from $41.00 to $60.00. On average, they expect Metlife's share price to reach $51.00 in the next twelve months. This suggests that the stock has a possible downside of 1.5%. View Analyst Price Targets for Metlife.
What is the consensus analysts' recommendation for Metlife?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 1 sell rating, 4 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Metlife.
What are Wall Street analysts saying about Metlife stock?
Here are some recent quotes from research analysts about Metlife stock:
- 1. According to Zacks Investment Research, "MetLife’s shares have outperformed its industry, year to date. It has been performing well led by prudent underwriting and expense management. Its efforts to streamline business and focus on core operations are impressive. Acquisitions made by the company will diversify its business and aid inorganic growth. Its disciplined capital deployment is expected to drive long-term growth and create wealth for shareholders. However, its exposure to catastrophe loss remains a concern. Investment in efficiency programs will likely put pressure on margins. Also, the company's net investment income might continue to decline in 2019 due to lower interest rates, which will likely pressurize investment yields." (12/9/2019)
- 2. Wells Fargo & Co analysts commented, "We do not expect much movement in the shares after our meetings. Our EPS estimates and price target are unchanged. We continue to have an Outperform rating on the shares." (6/5/2019)
Has Metlife been receiving favorable news coverage?
Media headlines about MET stock have trended somewhat positive on Friday, according to InfoTrie Sentiment. The research firm ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Metlife earned a daily sentiment score of 1.5 on InfoTrie's scale. They also assigned news articles about the financial services provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Metlife.
Are investors shorting Metlife?
Metlife saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 13,310,000 shares, an increase of 35.0% from the December 15th total of 9,860,000 shares. Based on an average daily volume of 4,780,000 shares, the short-interest ratio is presently 2.8 days. Approximately 1.7% of the shares of the stock are sold short. View Metlife's Current Options Chain.
Who are some of Metlife's key competitors?
Some companies that are related to Metlife include AFLAC (AFL), Prudential Financial (PRU), Principal Financial Group (PFG), Lincoln National (LNC), Unum Group (UNM), Primerica (PRI), CNO Financial Group (CNO), American Equity Investment Life (AEL), FBL Financial Group (FFG), National Western Life Group (NWLI), Independence (IHC), Citizens (CIA), Kansas City Life Insurance (KCLI) and Health Insurance Innovations (HIIQ).
What other stocks do shareholders of Metlife own?
Who are Metlife's key executives?
Metlife's management team includes the folowing people:
- Mr. Michel A. Khalaf, CEO, Pres & Director (Age 55)
- Mr. John Dennis McCallion CPA, Exec. VP & CFO (Age 45)
- Mr. Steven Jeffrey Goulart, Exec. VP & Chief Investment Officer (Age 60)
- Ms. Tamara L. Schock C.A., CPA, Exec. VP & Chief Accounting Officer (Age 47)
- Mr. John Arthur Hall, Sr. VP & Head of Investor Relations
Who are Metlife's major shareholders?
Metlife's stock is owned by many different of retail and institutional investors. Top institutional shareholders include SPF Beheer BV (0.19%), PGGM Investments (0.12%), Janney Montgomery Scott LLC (0.09%), Wedge Capital Management L L P NC (0.07%), Zurcher Kantonalbank Zurich Cantonalbank (0.06%) and 6 Meridian (0.04%). Company insiders that own Metlife stock include Carlos M Gutierrez, Gerald L Hassell, John D Mccallion, Steven A Kandarian and Steven J Goulart. View Institutional Ownership Trends for Metlife.
Which institutional investors are selling Metlife stock?
MET stock was sold by a variety of institutional investors in the last quarter, including Commerzbank Aktiengesellschaft FI, PGGM Investments, DNB Asset Management AS, Nisa Investment Advisors LLC, Meyer Handelman Co., Premier Asset Management LLC, Farmers & Merchants Investments Inc. and State of Alaska Department of Revenue. Company insiders that have sold Metlife company stock in the last year include John D Mccallion and Steven J Goulart. View Insider Buying and Selling for Metlife.
Which institutional investors are buying Metlife stock?
MET stock was bought by a variety of institutional investors in the last quarter, including WealthBridge Investment Counsel Inc., SPF Beheer BV, Summit X LLC, Wedge Capital Management L L P NC, Janney Montgomery Scott LLC, Exchange Traded Concepts LLC, Diversified Trust Co and BTR Capital Management Inc.. Company insiders that have bought Metlife stock in the last two years include Carlos M Gutierrez and Gerald L Hassell. View Insider Buying and Selling for Metlife.
How do I buy shares of Metlife?
Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Metlife's stock price today?
One share of MET stock can currently be purchased for approximately $51.80.
How big of a company is Metlife?
Metlife has a market capitalization of $47.64 billion and generates $67.94 billion in revenue each year. The financial services provider earns $5.12 billion in net income (profit) each year or $5.39 on an earnings per share basis. Metlife employs 48,000 workers across the globe.View Additional Information About Metlife.
What is Metlife's official website?
How can I contact Metlife?
Metlife's mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider can be reached via phone at 212-578-9500.
MarketBeat Community Rating for Metlife (NYSE MET)
MarketBeat's community ratings are surveys of what our community members think about Metlife and other stocks. Vote "Outperform" if you believe MET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MET will underperform the S&P 500 over the long term. You may vote once every thirty days.
